New Cochrane Review Confirms Efficacy of Robotic Gait Training
In a recent study on “Electromechanical-assisted training for walking after stroke“, Jan Mehrholz and his fellow researchers found significant evidence that stroke patients who received robot assisted gait training in combination with physiotherapy are more likely to achieve independent walking than patients that receive only conventional gait training.
Hocoma Celebrates the Sale of the 500th Neurorehabilitation Robot Lokomat®
Hocoma Announces First Early Rehabilitation Robotic Device With Integrated Stimulation
Hocoma Offers the World’s Only Upper Extremity Therapy Concept That Covers All Stages of Recovery
Launch of the World’s First Commercially Available Robotic Arm Exoskeleton
After being the first to release a robotic gait orthosis in 2001, the Swiss medical technology company Hocoma now presents the world’s first commercially available robotic arm exoskeleton. As a part of the established Armeo® Therapy Concept, the ArmeoPower was designed for severely affected individuals who have suffered neurological disorders resulting in hand and arm impairment. The ArmeoPower provides an assist-as-needed support in an extensive 3D workspace and a virtual reality exercise environment for a higher patient motivation. The ArmeoPower will further expand Hocoma’s market leadership in robotic rehabilitation therapy.